Realising the potential of correlates of protection for vaccine development, licensure and use: short summary

IF 6.9 1区医学 Q1 IMMUNOLOGY

NPJ Vaccines Pub Date : 2024-04-29 DOI:10.1038/s41541-024-00872-6

Deborah F. King, Helen Groves, Charlie Weller, Ian Jones, Jakob P. Cramer, Peter B. Gilbert, David Goldblatt, Marion F. Gruber, Beate Kampmann, Diadié Maïga, Marcela F. Pasetti, Stanley A. Plotkin, Alexander Precioso, Liya Wassie, Frederick Wittke, David C. Kaslow

引用次数: 0

Abstract

On 27–29th of September 2022, Wellcome convened an international multi-stakeholder workshop to discuss the use of Correlates of Protection (CoP) to accelerate vaccine development, the hybrid format meeting was attended by 80 delegates including developers, manufacturers, regulators, public health officials and policy-makers from 17 countries, including 7 LMIC’s.

Abstract Image

查看原文本刊更多论文

发挥保护相关性在疫苗开发、许可和使用方面的潜力：简短摘要

2022 年 9 月 27-29 日，惠康公司召开了一次国际多方利益相关者研讨会，讨论如何利用保护相关性（CoP）加速疫苗开发。来自 17 个国家（包括 7 个低收入和中等收入国家）的开发商、制造商、监管机构、公共卫生官员和政策制定者等 80 名代表参加了这次混合形式的会议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

NPJ Vaccines Immunology and Microbiology-Immunology

CiteScore

11.90

自引率

4.30%

发文量

146

审稿时长

11 weeks

期刊介绍： Online-only and open access, npj Vaccines is dedicated to highlighting the most important scientific advances in vaccine research and development.